CHLORDIAZACHEL Drug Patent Profile
✉ Email this page to a colleague
When do Chlordiazachel patents expire, and when can generic versions of Chlordiazachel launch?
Chlordiazachel is a drug marketed by Rachelle and is included in three NDAs.
The generic ingredient in CHLORDIAZACHEL is chlordiazepoxide hydrochloride. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlordiazachel
A generic version of CHLORDIAZACHEL was approved as chlordiazepoxide hydrochloride by CHARTWELL RX on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CHLORDIAZACHEL?
- What are the global sales for CHLORDIAZACHEL?
- What is Average Wholesale Price for CHLORDIAZACHEL?
Summary for CHLORDIAZACHEL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 15 |
| Patent Applications: | 3,324 |
| DailyMed Link: | CHLORDIAZACHEL at DailyMed |
US Patents and Regulatory Information for CHLORDIAZACHEL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rachelle | CHLORDIAZACHEL | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085086-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rachelle | CHLORDIAZACHEL | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 084639-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rachelle | CHLORDIAZACHEL | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085087-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
